bibliographic resource 1767429 [br/1767429]
https://w3id.org/oc/corpus/br/1767429

is a

• document
• article

title

• Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

publication date

• 2012-01-01

contributor

• https://w3id.org/oc/corpus/ar/6229499
• https://w3id.org/oc/corpus/ar/6229500
• https://w3id.org/oc/corpus/ar/6229501
• https://w3id.org/oc/corpus/ar/6229502
• https://w3id.org/oc/corpus/ar/6229503
• https://w3id.org/oc/corpus/ar/6229504
• https://w3id.org/oc/corpus/ar/6229505
• https://w3id.org/oc/corpus/ar/6229506
• https://w3id.org/oc/corpus/ar/6229507
• https://w3id.org/oc/corpus/ar/6229508
• https://w3id.org/oc/corpus/ar/6229509
• https://w3id.org/oc/corpus/ar/6229510
• https://w3id.org/oc/corpus/ar/6229511
• https://w3id.org/oc/corpus/ar/6229512
• https://w3id.org/oc/corpus/ar/6229513
• https://w3id.org/oc/corpus/ar/6229514
• https://w3id.org/oc/corpus/ar/6229515
• https://w3id.org/oc/corpus/ar/6229516
• https://w3id.org/oc/corpus/ar/6229517
• https://w3id.org/oc/corpus/ar/6229518
• https://w3id.org/oc/corpus/ar/6229519
• https://w3id.org/oc/corpus/ar/6229520
• https://w3id.org/oc/corpus/ar/6229521

format

• https://w3id.org/oc/corpus/re/891084

identifier

• https://w3id.org/oc/corpus/id/3204509
• https://w3id.org/oc/corpus/id/3204510
• https://w3id.org/oc/corpus/id/3204511

part of

• https://w3id.org/oc/corpus/br/28139